Methods

Experimental Preparation
The study was performed in adult mongrel dogs of either sex (n=30). The animals were premedicated with an injection of morphine sulfate (5 mg/kg s.c.) and anesthetized with a slow intravenous injection of a solution containing 5,5-diallylbarbituric acid (50 mg/ kg), urethane (200 mg/kg), and 2-imidazolidone (200 mg/kg). No additional anesthetics were required during the surgical procedure and experimental protocol. The trachea was intubated and artificial ventilation instituted, delivering oxygen-enriched air. Respiratory rate and tidal volume were adjusted to maintain arterial oxygen tension and pH within physiological limits throughout the experiment. A 0.9% saline solution was administered through the right femoral vein to compensate for perioperative fluid losses.
A left thoracotomy was performed in the sixth intercostal space. The pericardium was widely excised and the heart suspended in a pericardial cradle. A catheter including a high-fidelity micromanometer (Gaeltec, Dunvegan, Scotland) and a fluid-filled lumen connected to a Statham P231a transducer was advanced retrogradely through the left femoral artery into the LV cavity. The manometers were calibrated against a mercury column before the experiment. The zero was set at the level of the vertebral column. To correct for zeroline shifting, diastolic pressures of the micromanometer were matched with diastolic pressures of the fluid-filled catheter. Left atrial pressures were measured through a polyvinyl tube inserted into the left atrium through an incision in the left atrial appendage and connected to a Statham P231a transducer. A limb lead ECG was recorded throughout.
The right atrium was paced. A small sucking cup was fixed to the right atrial appendage. Two small rods in the wall of the cup were connected to an electrical stimulator (Grass S4, Quincy, Mass.) for bipolar stimulation of the appendage. Regional ventricular function was assessed with ultrasonic segment-length gauges, which were implanted in the anterior and posterior midventricle. Since we observed in a previous study3 that the anterior wall exhibited a nonuniform response to ultrasound from base to apex (i.e., a more pronounced response at the base than at the apex), we evaluated in the present study whether ultrasound also induced a nonuniform response of anterior and posterior midventricle. Each segment gauge was composed of two 5-MHz piezoelectric crystals with a diameter of 2 mm. Crystals were implanted approximately 1 cm apart through epicardial stab wounds and plunged into midwall. They were oriented in a circumferential direction, parallel to midwall fiber direction. The segment gauges were connected to a sonomicrometer amplifier system that was calibrated with time signals of known duration (Triton Technology Inc., San Diego, Calif.).
The EE was damaged with a custom-made ultrasound probe described previously.2.3 This system transformed a 25-W electrical signal into 0.9-MHz continuous-wave ultrasound. The probe was inserted into the LV cavity through a stab wound in the LV apex and secured in place with an epicardial purse-string suture. This suture crystal so that the probe was positioned between the mitral papillary muscles below the insertion of the chordae tendineae. The positions of the probe and segment-length gauges were verified by autopsy at the end of the experiment.
Effects of Intracavitary Ultrasound Irradiation
Irradiation of the endocardial surface with a source of high-power (25-W), high-frequency (900-kHz), continuous-wave ultrasound has been shown to induce selective morphological damage of the EE. This selective damage of the EE resulted in an altered myocardial function both in isolated cardiac muscle2 and in the intact ejecting ventricle.3 In isolated cardiac muscle, selective damage of EE by ultrasound immediately and irreversibly abbreviated isometric twitch duration, with concomitant slightly decreased peak twitch tension. These effects were quantitatively and qualitatively similar to the effects of previously used methods of EE damage. With all these techniques, the EE was selectively damaged without damage to the subjacent myocardium. Light microscopy, transmission electron microscopy, and lucifer yellow studies revealed damaged EE with a morphologically intact myocardium. readily apparent, end diastole was timed by the peak of the R wave on the ECG. Pressure at mitral valve opening was measured as the peak v-wave from the left atrial pressure tracing. Timing of mitral valve opening was determined by transposing the corresponding pressure onto the LV pressure tracing. Time intervals were measured from end diastole to peak (-)dP/dt, to mitral valve opening, and to minimum segment lengths. Rate of isovolumic relaxation was assessed with peak (-)dP/dt, time interval from peak (-)dP/dt to mitral valve opening, and time constant tau. Tau was calculated as the inverse slope of the linear relation of ln(pressure) versus time, assuming the asymptote of LV pressure to be 0 mm Hg and using LV pressures from peak (-)dP/dt to 5 mm Hg above mitral valve opening pressure.5,6 Sample correlation coefficient yielded values of r>0.98.
Segment lengths were measured at end diastole and at mitral valve opening. Minimum systolic length was measured as the minimum length preceding or coinciding with peak (-)dP/dt. Fractional shortening was calculated as the percent segment length change from end diastole to minimum segment length. Early segment reextension was calculated as the change from minimum segment length to segment length at mitral valve opening and was expressed as percent of enddiastolic length. Negative values indicated segment Hemodynamic data are shown in Figure 2 . Volume loading increased diastolic and systolic LV pressures, time from end diastole to peak (-)dP/dt, peak LV FIGURE 3. Bar graphs showing percentage effect of ultrasound on time interval from end diastole to peak (-)dP/dt and on time constant tau in the different experimental conditions. Upperpanel: Protocol A: Time intervalfrom end diastole to peak (-)dP/dt decreased by 7.8±2.3% (mean ±SEM) at low LVEDP (L), by 4.4±2.2% at mid (M), and by 1.9±1.6% at high LVEDP (H). Protocol B.: Time to peak (-)dPldt decreased by &4±3.1% at baseline (B) conditions and by 3.5±2.1% after calcium (Ca). Protocol C: Time to peak (-)dP/dt decreased by 5 Figure 2 . CaCl2 increased peak (+)dP/dt from 1,879+158 to 2,096±167 mm Hg/sec. Peak (-)dP/dt and LV pressures were hardly affected by the amount of CaCl2 administered. Likewise, none of these LV hemodynamic data changed with ultrasound. In the dose used in this protocol, CaCl2 did not alter time intervals or rate of LV pressure fall. Of note, time from end diastole to peak (-)dP/dt could be mildly shortened by CaCl2, but this was not observed systematically, given the slight dose of CaCl2 administered.
With ultrasound, time intervals decreased in both conditions, and this decrease was more pronounced at baseline than after CaCl2 (trial interaction, p<0.01). The time interval from end diastole to peak (-)dP/dt decreased by 8.4±3.1% at baseline (from 226±12 to 207±10 msec) and by 3.5±2.1% after CaCl2 (from 216±11 to 208±10 msec). Tau decreased by 11.1±4.8% at baseline (from 32±7 to 28±7 msec) and by 5.9±3.8% after CaCl2 (from 31±7 to 29±6 msec) (Figure 3 ).
Protocol C
This protocol compared the effects of ultrasound at baseline, after slight }3-blockade, under aortic constriction, and under mild selective a1-adrenergic stimulation with phenylephrine. A representative example of the effects of ultrasound in the different conditions is illustrated in Figure 6 . Ultrasound decreased time to peak (-)dP/dt. This effect was similar at baseline, after mild ,8-blockade with propranolol, and after aortic constriction but was more pronounced under phenylephrine infusion.
Hemodynamic data are shown in Figure 2 . Propranolol (0.1 mg/kg) increased the time interval from end diastole to peak (-)dP/dt (p<0.01). LV The results from the present study suggest that modulation of myocardial function by ultrasound interacts with heterometric and homeometric autoregulation of LV function and with a1-adrenergic agonism with phenylephrine.
The effects of ultrasound were significantly more pronounced at low volume. This finding indicated that the EE-mediated effects of ultrasound on LV performance were more important at low volume, and hence, that myocardial function could be particularly dependent on EE integrity when LV volume is decreased. Since the exact mechanisms by which EE modulates LV performance are still unknown,8-1' it is as yet speculative to explain why modulation of myocardial function by EE can be altered by LV volume. From in vitro experiments, it appeared that changes in twitch pattern induced by EE destruction (i.e., decreased twitch duration with minor changes in the rate of force development) were similar to changes induced by acute beat-to-beat reduction of initial fiber length at each calcium.' This observation suggested a common underlying mechanism. It could be that, as for length modulation of myocardial function,12,13 endocardial modulation of cardiac performance may also be mediated through changes in the sensitivity of the contractile proteins for calcium.',8 This hypothesis was endorsed by recent experiments.'4 If acute length modulation and endocardial modulation would act through the same mechanism, it is conceivable that when length modulation of myocardial performance is maximized, the effects of endocardial modulation would become less pronounced.
Decreased ultrasound irradiation intensities at higher volumes had to be ruled out as possible mechanisms for the decreased effect. With propagation through tissue or blood, some of the initial energy of the ultrasound wave is absorbed. The decrease in intensity has an exponential course, which can be calculated from the equation I=Io. 2 2I/H, where I is the actual intensity, Io is the intensity at the probe, x represents the distance from the ultrasonic probe, and H is the absorption coefficient of the specific tissue, i.e., the distance at which the intensity is diminished to half its initial value.15 H varies with the tissue, and its value in whole blood has been reported to be 20 cm for an ultrasound wave of 900 kHz,'6 so that ultrasound absorption as a consequence of increased distance to EE induced by volume loading should be negligible. We therefore evaluated in three additional dogs the effects observed when the power output was reduced by 50%. LVEDP was matched in these three dogs with low LVEDP in protocol A. From these experiments, it appeared that the functional and morphological effects of 4 minutes of irradiation with the same ultrasound probe at a power of 12.5 W were similar to the effects obtained at 25 W. This finding demonstrated that decreasing intensity of ultrasound in this range did not diminish the effects on LV function and hence, suggested that the decreased effects at higher volumes probably could not be attributed to changes in intensity with greater distance from the probe. In addition, the magnitude effects of ultrasound on time interval from end diastole to peak (-)dP/dt were related to the actual weight and LVEDP in all animals ( Figure 7 ). It appeared from this analysis that the magnitude of the effect of ultrasound was not related to the actual weight of the dog (p=0.53) but was clearly related to the actual LVEDP (p<0.001), indicating that the decreased effect of ultrasound at higher LVEDP could not be attributed to a greater distance of the ventricular wall from the ultrasound probe.
Pressure-length loops shifted to the right with ultrasound. This deviation was more pronounced at low LVEDP. End-systolic pressure-segment length ratio decreased more at low LVEDP. These findings confirmed a more pronounced negative inotropic effect of ultrasound at low LVEDP. The effects of ultrasound on LV performance were significantly more pronounced under phenylephrine infusion. The causes for this phenomenon remain to be established. It has to be ruled out that the observed effects were caused by increased peripheral resistance and systolic pressures with phenylephrine. The effects under phenylephrine were therefore compared with the effects after similar changes in LV systolic pressure obtained by slight constriction of the descending aorta. As is apparent from Figure 6 , both aortic constriction and phenylephrine infusion induced similar changes in systolic LV pressure values and systolic LV pressure waveform. Changes in time intervals, rate of LV pressure fall, and segment length values were not different from the ones observed under phenylephrine. Yet, the effect of ultrasound was significantly higher under phenylephrine than under aortic constriction. This difference suggested that the greater effects of ultrasound under phenylephrine were not likely to be caused by the effects of ultrasound on systemic hemodynamics but rather by an interaction of the EE-mediated effects of ultrasound and the effects of phenylephrine. This suggested that at least part of the inotropic activity of phenylephrine might be mediated through EE. Comparison of pressure increases induced by aortic constriction and phenylephrine has its limitations. However, the similar LV response to ultrasound before and after aortic constriction indicated that changes in systolic load did not affect magnitude of endocardial modulation significantly. Subtle differences between aortic constriction and administration of phenylephrine with regard to reflected waves and systolic LV wall stress, therefore, are not expected to explain a different response to ultrasound. In addition, these in vivo results corroborate the in vitro data, which demonstrated that part of the inotropic effects of phenylephrine were mediated through EE. 19 Another issue is that phenylephrine may also exert an effect on coronary circulation that might influence the response to ultrasound. However, the similarity of the present in vivo findings to the in vitro results provides circumstantial evidence that the magnitude of the effects of ultrasound depends on phenylephrine and not on the effects of ultrasound on coronary circulation. In addition, phenylephrine-induced changes in coronary flow might be expected to alter regional myocardial function, a phenomenon that was not apparent in our observations. 28 This lack of responsiveness was also reported in isolated cardiac muscle from patients with chronic heart failure. 29, 30 In view of the results of the present study, it is to be considered that this absence of findings could be the mere reflection of some EE damage secondary to the isolation procedure of the preparations or to EE functional impairment in congestive heart failure.
In conclusion, this study evaluated the effects of high-power, high-frequency, continuous-wave ultrasound at different LV volumes after low-dose calcium and in the presence of mild selective a,-adrenergic stimulation. It appeared that effects of ultrasound on LV performance were significantly higher at low volume, in the presence of lower calcium, and under a,-adrenergic stimulation with low-dose phenylephrine. Previous in vitro and in vivo studies linked these effects of ultrasound to a specific transient alteration of normal EE function. The present study, therefore, suggested that this EE-mediated effect of ultrasound might interact with regulation of myocardial function by volume, by calcium, and by low-dose phenylephrine.
It is essential to keep in mind that the intracavitary ultrasound technique used in the present experiments is significantly different from the technique used in the clinical setting for ultrasound imaging of the heart. The present ultrasound wave emits at 900 kHz in continuous-wave mode and has an electrical power density of 5 W/cm2. Commercially available transducers use pulsed waves with frequencies between 2 and 10 MHz and spatial peak temporal average intensities <100 mW/ cm2, the intensity below which no significant biological effects have been observed in mammalian tissues.3' This peak intensity, however, is applied only for a fraction (e.g., 0.1%) of total time.
